A naukri.com initiative
Bioengineer
3d
204
Image Credit: Bioengineer
Metabolic Adaptation Boosts Antioxidants, Cuts Glycation in Lung Cancer
- A study published in Nature Communications reveals a metabolic adaptation in non-small-cell lung cancer (NSCLC) patients enhancing antioxidative defense and reducing AGE formation.
- NSCLC remains challenging due to its aggressive nature, but understanding metabolic alterations is crucial for improving treatments.
- Oxidative stress due to ROS production can damage cells, leading to AGE formation, which contributes to cancer progression.
- Research shows enhanced antioxidative defense in NSCLC patients, mitigating ROS damage and reducing AGE burden.
- Upregulated antioxidant enzymes like SOD and GPx help cancer cells maintain function amidst increased metabolic activity.
- Reduced AGE accumulation in tumors of NSCLC patients indicates metabolic adaptation blunting pro-oncogenic pathways.
- NSCLC cells divert glucose metabolites to favor antioxidative molecule synthesis for redox balance and cellular resilience.
- Sustained NRF2 activation drives metabolic adaptation, offering therapeutic implications for targeting cancer metabolism.
- Patients with higher antioxidative profiles in tumors may have distinct clinical outcomes, suggesting a potential biomarker for prognosis.
- The study highlights the duality of antioxidative defense in cancer biology and proposes targeting these systems to sensitize cancer cells.
Read Full Article
12 Likes
For uninterrupted reading, download the app